Delving into the Latest Updates on Arpida AG with Synapse

概览

关联

7

项与 Arpida AG 相关的临床试验

EUCTR2006-005895-42-IS / Not yet recruitingN/A

A study to determine the safety and efficacy of a terbinafine topical formulation system in subjects with onychomycosis in laser treated toenails versus ciclopirox lacquer in intact toenails

开始日期2009-03-02

申办/合作机构

TLT Medical Ltd.

NCT00543608 / Terminated临床2期

Randomized, Double-Blind, Multicenter Study to Evaluate Efficacy and Safety of Intravenous Iclaprim Versus Vancomycin in the Treatment of Hospital-Acquired, Ventilator-Associated, or Health-Care-Associated Pneumonia Suspected or Confirmed to be Due to Gram-Positive Pathogens

The purpose of this study is to compare the clinical cure rates of two dosing regimens of iclaprim with vancomycin (every 12 hours [q12h]) in the treatment of patients with hospital-acquired pneumonia (HAP), ventilator-associated pneumonia (VAP), or health-care-associated pneumonia (HCAP) suspected or confirmed to be due to Gram-positive pathogens.

开始日期2007-11-01

申办/合作机构

Arpida AG

EUCTR2007-003109-28-LV / Not yet recruitingN/A

Randomized, double-blind, multicenter study to evaluate efficacy and safety of intravenous iclaprim versus vancomycin in the treatment of hospital-acquired, ventilator-associated, or health-care-associated pneumonia suspected or confirmed to be due to Gram-positive pathogens

开始日期2007-07-27

申办/合作机构

Arpida AG

100 项与 Arpida AG 相关的临床结果

登录后查看更多信息

0 项与 Arpida AG 相关的专利（医药）

登录后查看更多信息

100 项与 Arpida AG 相关的药物交易

登录后查看更多信息

100 项与 Arpida AG 相关的转化医学

登录后查看更多信息